DON'T BUY
Prospects are still uncertain.
DON'T BUY
Advertising is very soft. Not sure of management.
DON'T BUY
Need to get FDA approval. Too speculative for their funds.
DON'T BUY
A slowdown in world economy. Steel could be vulnerable to US duties because of bias re Iraqi war.
DON'T BUY
A difficult company to analyze.
BUY
Good buying opportunity. Hold until next Feb when gas will be high again. Expects gas will be at very high levels next winter.
PAST TOP PICK
(Was a top pick on Dec 17. Up 3.8%) Sold out at a profit when Manulife made a bid on Canada Life.
PAST TOP PICK
(Was a top pick on Dec 17. Up 3% plus the 9% annual dispersments received.) Still likes. Safe. Stable.
PAST TOP PICK
(Was a top pick on Dec 17. Up 13.3%) Still likes. Good products.
DON'T BUY
Thinly traded. In a losing track.
DON'T BUY
Debt free. Has lost money and is forcasting losing more. Has a lot of competition.
DON'T BUY
Retail market is affected by Wal-Mart competition. Well managed.
BUY
Dividend should be secure. A new stock issue diluted the share price. Well managed.
DON'T BUY
Driven by news. Treat as a trading stock. Insider trading has been a problem. Volatile.